Developing a new adjuvant for malaria vaccines
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
This study is testing a new ingredient called 7DW8-5 that could make malaria vaccines work better, and it's aimed at helping people who need more effective and easier-to-use vaccines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11127342 on NIH RePORTER |
What this research studies
This research focuses on creating a glycolipid-based adjuvant called 7DW8-5 to enhance the effectiveness of malaria vaccines. The approach involves using a novel compound that stimulates natural killer T cells, which are crucial for immune response. The research will evaluate the adjuvant's formulation, stability, and safety in both laboratory settings and non-human primates before moving towards regulatory approval for human use. Patients may benefit from improved malaria vaccines that are more effective and easier to administer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of malaria, particularly those living in endemic regions.
Not a fit: Patients who are not at risk of malaria or those who have already been vaccinated against malaria may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective malaria vaccines, potentially reducing the incidence of malaria in affected populations.
How similar studies have performed: Previous research has shown success with similar adjuvant approaches in enhancing vaccine efficacy, indicating a promising avenue for malaria vaccine development.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Tsuji, Moriya — Columbia University Health Sciences
- Study coordinator: Tsuji, Moriya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.